Impairment
12
0
0
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (12)
Evaluation of Smoked THC and CBD in Men and Women
Evaluation of Oral THC and CBD in Men and Women
Alcohol Impairment Detection in Healthy Adult Users With the Gaize Device
Physical and Cognitive Impairments in People Suffering From Long COVID
Validation of Driving Simulator to Blood Alcohol Concentration Standards for Impaired Driving
Neurophysiology of Weakness and Exercise in Rotator Cuff Tendinopathy
Asynchronous Techniques for the Delivery of Empirically Supported Psychotherapies
Eye Movement Tracking to Detect Impairment Due to Acute Cannabis Intoxication
How Much The Self-Reported Physical Activity Change in Patients With Physical Disabilities Hospitalized for Rehabilitation in A Physical Medicine and Rehabilitation Clinic
Can a Relaxometer Improve Cognitive Impairment of Fibromyalgia Patients
Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families
Assessment of Service and Hearing Dogs